- Their two recent studies have uncovered new information about clonal hematopoiesis and its treatment with the anti-inflammatory drug colchicine.
- Researchers from the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Spain have confirmed that clonal hematopoiesis is a risk factor for atherosclerosis, the underlying cause of most cardiovascular diseases.
- This new information could lead to the development of novel personalized treatments for patients in the future.
Read the full article here